The assessment available on Midnight Metabolism website does not create a doctor-patient relationship. Clinical services are provided by OpenLoop Health and other networks of U.S.-licensed clinicians who determine eligibility for GLP-1 treatment based on medical history and assessment responses. Providers retain full discretion to prescribe or decline compounded GLP-1 medications. Compounded medications offered through Midnight Metabolism are produced in FDA-registered facilities but are not FDA-approved and have not been evaluated by the FDA for safety, efficacy, or quality. Results may vary and depend on individual adherence, provider guidance, and lifestyle changes. Midnight Metabolism does not manufacture compounded medications, and product appearance may differ from website images. Midnight Metabolism partners with certified U.S. pharmacies to ensure high standards of safety and quality. Medication costs are included in the Midnight Metabolism program. Zepbound® is FDA-approved for chronic weight management; Ozempic® is FDA-approved for type 2 diabetes treatment but may be prescribed off-label for weight management. All trademarks are the property of their respective owners. Unless otherwise noted, results reflect Midnight Metabolism patient experiences rather than public clinical studies.
Copyright 2026 Midnight Metabolism. All rights reserved.
